The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V08 | Contrast media | |
| 3 | V08D | Ultrasound contrast media | |
| 4 | V08DA | Ultrasound contrast media |
| Code | Title | |
|---|---|---|
| V08DA01 | ||
| V08DA02 | Microparticles of galactose | |
| V08DA03 | Perflenapent | |
| V08DA04 | ||
| V08DA05 | ||
| V08DA06 |
| Active Ingredient | Description | |
|---|---|---|
| Perflutren |
When used in conjunction with diagnostic ultrasound, perflutren provides opacification of cardiac chambers, improvement in delineation of endocardial borders, enhancement of the Doppler signal, and visualisation of wall motion and blood flow within the heart. |
|
| Sulfur hexafluoride |
Sulphur hexafluoride is an inert, innocuous gas, poorly soluble in aqueous solutions. Sulphur hexafluoride is for use with ultrasound imaging to enhance the echogenicity of the blood, or of fluids in the urinary tract which results in an improved signal to noise ratio. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DEFINITY Suspension for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| LUMINITY Gas and solvent for dispersion for injection/infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| OPTISON Dispersion for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| SONOVUE Powder and solvent for dispersion for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
